These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 5054211)

  • 1. Is metaraminol a selective monoamine oxidase inhibitor?
    Manara L; Carminati P
    Adv Biochem Psychopharmacol; 1972; 5():421-2. PubMed ID: 5054211
    [No Abstract]   [Full Text] [Related]  

  • 2. Metaraminol and monoamineoxidase activity in the rat heart.
    Bareggi SR; Carminati P; Manara L
    Res Commun Chem Pathol Pharmacol; 1971 May; 2(3):347-54. PubMed ID: 5149892
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase.
    Shore PA
    Pharmacol Rev; 1966 Mar; 18(1):561-8. PubMed ID: 4379288
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoamine oxidase (MAO) activity in the rat heart after a single dose of ethyl alcohol.
    Pieczul J; Samochowiec L; Wójcicki J
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):267-9. PubMed ID: 5420947
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential development, inhibition, and recovery of monoamine oxidase in various parts of the rat heart.
    Horita A
    Res Commun Chem Pathol Pharmacol; 1970 Nov; 1(6):713-20. PubMed ID: 5524271
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacologic properties of metaraminol in rats].
    Cession-Fossion A
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):421-8. PubMed ID: 5684253
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of methyldopa and related agents on pressor responses to tyramine in reserpine-pretreated rats and dogs.
    Torchiana ML; Wenger HC; Stavorski J; Ludden CT; Stone CA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):242-52. PubMed ID: 5932601
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-pharmacological model of paroxysmal arterial hypertension].
    Sicuteri F; Del Bene E; Tarquini B; Fanciullacci M
    Rass Neurol Veg; 1968; 22(1):63-82. PubMed ID: 5718883
    [No Abstract]   [Full Text] [Related]  

  • 9. Migraine-headache and essential arterial hypertension. A clinical pharmacological approach with the false transmitter metaraminol.
    Sicuteri F; Del Bianco PL; Del Bene E
    Res Clin Stud Headache; 1970; 3():284-98. PubMed ID: 5527209
    [No Abstract]   [Full Text] [Related]  

  • 10. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1970 Jan; 171(1):80-7. PubMed ID: 5410940
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on monoamine oxidase of rat heart mitochondria. I. Purification and properties of the enzyme.
    Sen R; Parmar SS; Guha SR
    Acta Biol Med Ger; 1968; 21(1):1-11. PubMed ID: 5724353
    [No Abstract]   [Full Text] [Related]  

  • 13. The inhibition of human heart monoamine oxidase [proceedings].
    Callingham BA; Parkinson D
    Br J Pharmacol; 1977 Nov; 61(3):470P-471P. PubMed ID: 588821
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of action of adrenaline and some other biogenic amines on gamma-amylase activity of rat liver and heart muscle].
    Orlova VS; Siniukhin VN; Popova IA; Gorkin VZ; Rozenfel'd EL
    Biokhimiia; 1971; 36(3):555-61. PubMed ID: 5132486
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the uptake and subcellular distribution of catecholamines and their alpha-methylated analogues.
    Lundborg P
    Acta Physiol Scand Suppl; 1967; 302():1-34. PubMed ID: 5584149
    [No Abstract]   [Full Text] [Related]  

  • 18. Catechol-O-methyl transferase and monoamine oxidase activities in the heart and liver of the embryonic and developing chick.
    Ignarro LJ; Shideman FE
    J Pharmacol Exp Ther; 1968 Jan; 159(1):29-37. PubMed ID: 5643948
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual pattern of beta-phenylethylamine deamination in the rat heart.
    Tiago Guimarães J; Soares-da-Silva P
    Neurobiology (Bp); 2000; 8(1):109-18. PubMed ID: 11008882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA; Davies B; Castagnoli N
    Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.